Ultragenyx Pharmaceutical RARE
NASDAQ RARE
$15.20 -0.11 (-0.75%)
As of: Sep 30, 2026 · 3:28 PM EDT

Ultragenyx Pharmaceutical (RARE) Receivables - Net (2013 - 2026)

Updated

Ultragenyx Pharmaceutical (RARE) posted Receivables - Net of $200 million for Q2 2026, up 60.7% from $124.46 million a year earlier and up 65.3% from the prior quarter.

Analysis

Ultragenyx Pharmaceutical (RARE) Receivables - Net (2013 - 2026) Analysis & Trends

At the end of FY2025, Ultragenyx Pharmaceutical's Receivables - Net came in at $158 million, up 29.5% from FY2024.

  • Annual Receivables - Net has increased for five consecutive years, with a five-year compound annual growth rate of 46.9% (FY2020 to FY2025).
  • In prior years, Ultragenyx Pharmaceutical's Receivables - Net was $122 million in FY2024 (+66.2%), $73.39 million in FY2023 (+81.5%), $40.45 million in FY2022 (+42.3%) and $28.43 million in FY2021 (+23.1%).
  • The Q2 2026 figure stands as the highest quarterly Receivables - Net in data going back to Q4 2013.
  • On a year-over-year basis, Receivables - Net has increased in each of the last five quarters, with growth averaging 33.7% over the last eight quarters.
  • The strongest year-over-year quarter for Receivables - Net in the past five years was Q3 2023, with growth of 154.3%; the weakest was Q3 2021, with a decline of 8.6%.
  • According to Business Quant data, Receivables - Net for the three prior quarters was $121 million (Q1 2026), $98 million (Q4 2025) and $112.54 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Ultragenyx Pharmaceutical 1.51 Bn -292.70 Mn 180.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 200.00 Mn
Mar 31, 2026 121.00 Mn
Dec 31, 2025 98.00 Mn
Sep 30, 2025 112.54 Mn
Jun 30, 2025 124.46 Mn
Mar 31, 2025 98.84 Mn
Dec 31, 2024 85.00 Mn
Sep 30, 2024 93.30 Mn
Jun 30, 2024 105.98 Mn
Mar 31, 2024 100.25 Mn
Dec 31, 2023 39.20 Mn
Sep 30, 2023 79.26 Mn
Jun 30, 2023 70.52 Mn
Mar 31, 2023 42.99 Mn
Dec 31, 2022 27.50 Mn
Sep 30, 2022 31.16 Mn
Jun 30, 2022 37.21 Mn
Mar 31, 2022 28.37 Mn
Dec 31, 2021 20.20 Mn
Sep 30, 2021 25.38 Mn
API Access

Ultragenyx Pharmaceutical Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=RARE&period=max&api_key=YOUR_API_KEY